Pham Paul, Bindra Jessica, Chuan Alwin, Jaeger Matthias, Aneman Anders
Faculty of Medicine, University of New South Wales, Sydney, Australia.
Department of Anaesthesia, Liverpool Hospital, South Western Sydney Local Health District, Sydney, Australia; University of New South Wales, South Western Sydney Clinical School, Liverpool, Australia.
Resuscitation. 2015 Nov;96:192-8. doi: 10.1016/j.resuscitation.2015.08.007. Epub 2015 Aug 24.
To investigate the association between impaired cerebrovascular autoregulation (CVAR) and outcome in comatose survivors of cardiac arrest.
The correlation in the time domain between cerebral tissue oxygenation (cStO2) using near infrared spectroscopy (NIRS) and mean arterial pressure was used to determine the tissue oxygenation index (TOx) as a reflection of normal (TOx<0) or impaired (TOx>0) CVAR. Daily measurements (>1h recording time) were performed in the first three days post cardiac arrest. Survival and neurological outcome was assessed at three months following cardiac arrest. A control group of healthy volunteers was also investigated.
23 patients and 28 volunteers were studied. All survivors (n=8) of cardiac arrest had a good neurological outcome. The TOx (median [interquartile range] for days 1-3) was higher (Mann Whitney test, p<0.001) in non-survivors (0.04 [-0.02 to -0.16]) compared to survivors (-0.11 [-0.19 to -0.02]) and healthy volunteers (-0.15 [-0.27 to -0.04]) on every day and for days 1-3 following cardiac arrest. The TOx was not significantly different between survivors and healthy volunteers. The cStO2 did not discriminate survivors (67 [62-72]%) from non-survivors (71 [65-75]%). Logistic regression analysis demonstrated TOx to be independently associated with survival at three months post cardiac arrest (odds ratio [95% confidence interval] 0.01 [0.01-0.50], p=0.04).
Early impairment of CVAR following cardiac arrest is independently associated with mortality at three months follow-up. Assessments of CVAR could add to the management and prognostication during post-resuscitation care and should be further investigated as a guide to optimise cerebral perfusion pressure.
研究心脏骤停昏迷幸存者脑血管自动调节功能(CVAR)受损与预后之间的关系。
采用近红外光谱法(NIRS)测定脑组织氧合(cStO2)与平均动脉压在时域上的相关性,以确定组织氧合指数(TOx),作为正常(TOx<0)或受损(TOx>0)CVAR的反映。在心脏骤停后的前三天进行每日测量(记录时间>1小时)。在心脏骤停三个月后评估生存情况和神经功能预后。还对一组健康志愿者进行了研究。
共研究了23例患者和28名志愿者。所有心脏骤停幸存者(n=8)神经功能预后良好。在心脏骤停后的每一天以及第1 - 3天,非幸存者(0.04 [-0.02至-0.16])的TOx(第1 - 3天的中位数[四分位间距])高于幸存者(-0.11 [-0.19至-0.02])和健康志愿者(-0.15 [-0.27至-0.04])(Mann-Whitney检验,p<0.001)。幸存者和健康志愿者之间的TOx无显著差异。cStO2不能区分幸存者(67 [62 - 72]%)和非幸存者(71 [65 - 75]%)。逻辑回归分析表明,TOx与心脏骤停后三个月的生存率独立相关(优势比[95%置信区间] 0.01 [0.01 - 0.50],p = 0.04)。
心脏骤停后早期CVAR受损与三个月随访时的死亡率独立相关。CVAR评估可辅助复苏后护理期间的管理和预后判断,作为优化脑灌注压的指导应进一步研究。